Krebs Biochemicals (India) Investor Sentiment

KREBSBIO   104.14  8.79  7.78%   
Under 62% of Krebs Biochemicals' investor base is looking to short. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that many investors are alarmed at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
  
over two weeks ago at news.google.com         
Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67 percent Y-o-Y - Mone...
Google News at Macroaxis
over two weeks ago at news.google.com         
Krebs Biochemicals Industries reports standalone net loss of Rs 5.76 crore in the September 2024 qua...
Google News at Macroaxis
over a month ago at news.google.com         
Ipca Laboratories Share price and Fundamental Analysis - Trade Brains
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industries Ltd Announces Unaudited Standalone Financial Results for the Quarter a...
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industr Q1 Results Live loss falls by 3.03 percent YOY Company Business News - Mi...
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter ...
Google News at Macroaxis
over three months ago at news.google.com         
Price Volume breakout stocks These stocks likely to be in focus tomorrow - Dalal Street Investment J...
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industries Ltd leads gainers in B group - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Indices trade flat IT shares advance - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industries Ltd leads gainers in B group - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industries Ltd leads gainers in B group - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Krebs Biochemicals Industries Ltd leads gainers in B group - Business Standard
Google News at Macroaxis
over six months ago at news.google.com         
Serratiopeptidase Market to Witness Phenomenal Growth Beloorbayir Biotech, Krebs Biochemicals Indust...
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industr Q4 Results Live loss falls by 15.75 percent YOY - Mint
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industr Q4 Results Live loss falls by 15.75 percent YOY Company Business News - M...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Krebs Biochemicals that are available to investors today. That information is available publicly through Krebs media outlets and privately through word of mouth or via Krebs internal channels. However, regardless of the origin, that massive amount of Krebs data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Krebs Biochemicals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Krebs Biochemicals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Krebs Biochemicals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Krebs Biochemicals alpha.

Krebs Biochemicals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67 percent Y-o-Y - Moneycontrol
11/12/2024

Complementary Tools for Krebs Stock analysis

When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes